Uniqure Nv

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$44.00

-0.09 (-0.20%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target -60.2% upside

Low Target $11.65

Average Target $17.51

High Target $27.07

Current Price $44.00

Current
$44.00

Target
$17.51

$11.65 $17.51 avg $27.07

Scenario Analysis

Bear Case

$11.65

-73.5%

Low target

Base Case

$17.51

-60.2%

Avg target

Bull Case

$27.07

+-38.5%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$71.50

-38.5% from high

52-Week Low

$8.73

+404.0% from low

Target vs 52W High

$17.51

-75.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.2%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%